← Back
$BBNX All transactions

Beta Bionics, Inc.

M 10b5-1 Plan

$ Value

$3K

Shares

656

Price

$5

Filed

Sep 8

Insider

Name

Hopman Mark

Title

Chief Commercial Officer

CIK

0002048497

Roles

Officer

Transaction Details

Transaction Date

2025-09-04

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

33,940

Footnotes

Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025. | The weighted average sale price for the transaction reported was $19.9736 and the range of prices were between $19.43 and $20.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | The weighted average sale price for the transaction reported was $20.564162 and the range of prices were between $20.29 and $20.80. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof. | The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.

Filing Info

Accession No.

0001415889-25-023899

Form Type

4

Issuer CIK

0001674632

Hopman Mark's History

Date Ticker Type Value
2026-03-04 BBNX $4K
2026-03-02 BBNX $10K
2026-02-27 BBNX A $0
2026-02-27 BBNX A $0
2026-02-27 BBNX A $0
2025-12-04 BBNX $63K
2025-12-02 BBNX $25K
2025-09-05 BBNX M $58K
2025-09-05 BBNX $235K
2025-09-05 BBNX M $0

Other Insiders at BBNX (90d)

Insider Bought Sold Last
Hopman Mark
Chief Commercial Officer
$103K 2026-03-04
Mensinger Mike
Chief Product Officer
$13K 2026-03-02
Feider Stephen
Chief Financial Officer
$18K 2026-03-02
Saint Sean
President & CEO
$42K 2026-03-02
Russell Steven Jon
Chief Medical Officer
$43K 2026-03-02